Invention Grant
US09095589B2 Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
有权
伊曲康唑的chirally纯异构体用作血管发生抑制剂
- Patent Title: Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
- Patent Title (中): 伊曲康唑的chirally纯异构体用作血管发生抑制剂
-
Application No.: US13444642Application Date: 2012-04-11
-
Publication No.: US09095589B2Publication Date: 2015-08-04
- Inventor: Jun O. Liu , Curtis R. Chong , Jing Xu , Jun Lu , Shridhar Bhat , Wie Shi
- Applicant: Jun O. Liu , Curtis R. Chong , Jing Xu , Jun Lu , Shridhar Bhat , Wie Shi
- Applicant Address: US MD Baltimore
- Assignee: Johns Hopkins University
- Current Assignee: Johns Hopkins University
- Current Assignee Address: US MD Baltimore
- Agency: DLA Piper LLP (US)
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/4178 ; A61K45/06
Abstract:
Described herein are methods of inhibiting angiogenesis, and treating and preventing disorders associated with angiogenesis by administering anti-angiogenesis compounds to a subject.
Public/Granted literature
- US20130102614A1 CHIRALLY PURE ISOMERS OF ITRACONAZOLE FOR USE AS ANGIOGENESIS INHIBITORS Public/Granted day:2013-04-25
Information query
IPC分类:
